Delivery Order SPE2DB22D1202-SPE2DB25FVFE9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,702.10 to AmerisourceBergen Drug Corp for Lamictal XR 200 mg tablets (30-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.99 to AmerisourceBergen Drug Corp for the supply of Lamictal XR 50 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,310.81 to AmerisourceBergen Drug Corp for Lamictal XR 250 mg tablets (30-count units) on August 1, 2025, with a completion deadline of August 4, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lamictal XR (lamotrigine extended-release) is an anticonvulsant medication commonly used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lamictal XR 50 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $4,466.95. The award, issued on August 4, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of LAMICTAL XR 250 MG TABLET 30S. The contract has a firm fixed price of $67,462.79 and a period of performance through July 1, 2025. The contract is not set aside and was awarded on June 30, 2025. Amerisourcebergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania, and is a critical...
- This is a $5,928.75 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg Lamictal XR tablets. The contract has a period of performance through July 13, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Lamictal 150 mg on August 13, 2025, with a ceiling value of $2,273.15. This is a firm fixed-price delivery order with an ultimate completion date of August 14, 2025. The contract is not set-aside and represents a competitive award to the prime contractor. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LAMICTAL XR 250 MG TABLET 30S. The $13,637.86 firm fixed price contract has an ultimate completion date of October 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamictal 25 mg tablets (100-count units) valued at $19,868.41 on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,318.13 firm-fixed-price delivery order is for the supply of LAMICTAL XR 250 MG TABLET 30S, a prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFE9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,432.53 on July 22, 2025, for Lamictal XR 250 mg tablets (30-count packages). The contract is a firm fixed price delivery order without set-aside designation, with an ultimate completion date of July 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that authorizes the distributor to supply an extensive portfolio of pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that regularly fulfills federal medical procurement requirements through competitively awarded contracts with the Defense Logistics Agency and its Medical Supply Chain, delivering products across multiple therapeutic domains including specialty medications, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 7/22/25 |